Skip to content

HTG Molecular Diagnostics, Inc.

CIK 0001169987

← back to feed
Revenue (TTM)
$4.96M
−28.5% YoY Q1 May 2023
Net Income (TTM)
−$21.96M
−26.0% YoY Q1 May 2023
EPS Diluted (TTM)
−$12.96
+18.1% YoY Q1 May 2023
Gross Margin
253.7%
Q1 May 2023
Operating Margin
-429.3%
Q1 May 2023
Net Margin
-442.7%
Q1 May 2023
Free Cash Flow (TTM)
−$18.73M
Q1 May 2023
Cash
$3M
Q1 May 2023
Total Debt
$2.45M
Q1 May 2023
Shares Outstanding
2.21M sh
Q1 May 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings